These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 9514958)

  • 1. An aspartic acid residue near the second transmembrane segment of ATP receptor/channel regulates agonist sensitivity.
    Nakazawa K; Ohno Y; Inoue K
    Biochem Biophys Res Commun; 1998 Mar; 244(2):599-603. PubMed ID: 9514958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor.
    King BF; Wildman SS; Ziganshina LE; Pintor J; Burnstock G
    Br J Pharmacol; 1997 Aug; 121(7):1445-53. PubMed ID: 9257926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular histidine residues identify common structural determinants in the copper/zinc P2X2 receptor modulation.
    Lorca RA; Coddou C; Gazitúa MC; Bull P; Arredondo C; Huidobro-Toro JP
    J Neurochem; 2005 Oct; 95(2):499-512. PubMed ID: 16190872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conserved negatively charged residues are not required for ATP action at P2X(1) receptors.
    Ennion SJ; Ritson J; Evans RJ
    Biochem Biophys Res Commun; 2001 Dec; 289(3):700-4. PubMed ID: 11726204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular determinants of the agonist binding domain of a P2X receptor channel.
    Yan Z; Liang Z; Tomic M; Obsil T; Stojilkovic SS
    Mol Pharmacol; 2005 Apr; 67(4):1078-88. PubMed ID: 15632318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH.
    Wildman SS; King BF; Burnstock G
    Br J Pharmacol; 1998 Mar; 123(6):1214-20. PubMed ID: 9559907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenesis studies of conserved proline residues of human P2X receptors for ATP indicate that proline 272 contributes to channel function.
    Roberts JA; Evans RJ
    J Neurochem; 2005 Mar; 92(5):1256-64. PubMed ID: 15715674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning and pharmacological characterization of a fourth P2X receptor subtype widely expressed in brain and peripheral tissues including various endocrine tissues.
    Wang CZ; Namba N; Gonoi T; Inagaki N; Seino S
    Biochem Biophys Res Commun; 1996 Mar; 220(1):196-202. PubMed ID: 8602843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory interdependence of cloned epithelial Na+ channels and P2X receptors.
    Wildman SS; Marks J; Churchill LJ; Peppiatt CM; Chraibi A; Shirley DG; Horisberger JD; King BF; Unwin RJ
    J Am Soc Nephrol; 2005 Sep; 16(9):2586-97. PubMed ID: 16000699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of P2X2 receptor/channel pore mutants.
    Nakazawa K; Ohno Y
    Eur J Pharmacol; 2004 Jul; 495(1):27-33. PubMed ID: 15219817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a site that modifies desensitization of P2X2 receptors.
    Zhou Z; Monsma LR; Hume RI
    Biochem Biophys Res Commun; 1998 Nov; 252(3):541-5. PubMed ID: 9837742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An asparagine residue regulating conductance through P2X2 receptor/channels.
    Nakazawa K; Inoue K; Ohno Y
    Eur J Pharmacol; 1998 Apr; 347(1):141-4. PubMed ID: 9650860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
    Evans RJ; Lewis C; Buell G; Valera S; North RA; Surprenant A
    Mol Pharmacol; 1995 Aug; 48(2):178-83. PubMed ID: 7544432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.
    von Kügelgen I
    Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
    Vandenberg RJ; Rajendra S; French CR; Barry PH; Schofield PR
    Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the histidyl residue obligatory for the catalytic activity of the human H+/peptide cotransporters PEPT1 and PEPT2.
    Fei YJ; Liu W; Prasad PD; Kekuda R; Oblak TG; Ganapathy V; Leibach FH
    Biochemistry; 1997 Jan; 36(2):452-60. PubMed ID: 9003198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of conserved glycine residues to ATP action at human P2X1 receptors: mutagenesis indicates that the glycine at position 250 is important for channel function.
    Digby HR; Roberts JA; Sutcliffe MJ; Evans RJ
    J Neurochem; 2005 Dec; 95(6):1746-54. PubMed ID: 16236030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pore dilation of neuronal P2X receptor channels.
    Virginio C; MacKenzie A; Rassendren FA; North RA; Surprenant A
    Nat Neurosci; 1999 Apr; 2(4):315-21. PubMed ID: 10204537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Block and unblock by imipramine of cloned and mutated P2X2 receptor/channel expressed in Xenopus oocytes.
    Nakazawa K; Inoue K; Ohno Y
    Neurosci Lett; 1999 Apr; 264(1-3):93-6. PubMed ID: 10320022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.